Corpus Intelligence IC Memo — MID JEFFERSON EXTENDED CARE HOSPT. 2026-04-26 15:42 UTC
IC Memo — MID JEFFERSON EXTENDED CARE HOSPT.
Investment Committee Memorandum | TX | 30 beds | Grade D | EBITDA uplift $1.5M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

MID JEFFERSON EXTENDED CARE HOSPT.

CCN 452083 | JEFFERSON, TX | 30 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

MID JEFFERSON EXTENDED CARE HOSPT. is a 30-bed community hospital in JEFFERSON, TX with $19.8M in net patient revenue and a 1.9% operating margin. The hospital serves a payer mix of 87.6% Medicare, 0.0% Medicaid, and 12.4% commercial.

Thesis: Turnaround. Our ML models identify $1.5M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 1.9% to 9.3% (+736bps).

Net Revenue HCRIS$19.8M
Current EBITDA COMPUTED$382K
Operating Margin COMPUTED1.9%
Occupancy HCRIS46.9%
Revenue / Bed COMPUTED$660K
Net-to-Gross HCRIS45.5%
Distress Probability MLnan%

2. Market Context & Competitive Position

583
TX Hospitals
-0.7%
State Median Margin
277
Comparable Hospitals

TX has 583 Medicare-certified hospitals with a median operating margin of -0.7%. The target's margin of 1.9% places it above the state median. Among 277 size-comparable peers (15-60 beds), the median margin is -4.0%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (15-60), prioritizing same-state peers. 277 hospitals in the comp set.

HospitalStateBedsRevenueMargin
MID JEFFERSON EXTENDED CARE HO (Target)TX30$19.8M1.9%
WISE HEALTH SYSTEM - PARKWAYTX36$361.0M-15.5%
CORYELL MEMORIAL HOSPITALTX25$305.9M-1.5%
BAYLOR HEART AND VASCULAR HOSPTX53$255.0M30.0%
TEXAS ORTHOPEDIC HOSPITATX42$237.8M46.3%
LAKE GRANBURY MEDICAL CENTERTX53$181.6M38.5%
METHODIST HOSPITAL FOR SURGERYTX32$178.4M22.8%
TEXAS SPINE AND JOINT HOSPITALTX20$147.3M30.3%
NORTH CENTRAL SURGICAL HOSPITATX24$143.6M32.0%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $1.5M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$416K+210bp18mo
Cost to Collect4.5%2.5%$396K+200bp12mo
Denial Rate Reduction12.0%6.5%$392K+198bp12mo
A/R Days Reduction5200.0%3800.0%$241K+122bp9mo
Clean Claim Rate88.0%96.0%$13K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$416K
Cost to Collect
$396K
Denial Rate Reduction
$392K
A/R Days Reduction
$241K
Clean Claim Rate
$13K
Total EBITDA Uplift$1.5M
Current EBITDA$382K
+ RCM Uplift+$1.5M
Pro Forma EBITDA$1.8M
Current Margin1.9%
Pro Forma Margin9.3%
WC Released (1x)$759K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$588K$17.1M29.08x96.2%
Base (11x exit)10.0x11.0x$588K$19.0M32.31x100.4%
Bull Case9.0x11.0x$529K$24.0M45.35x114.4%
Bull (12x exit)9.0x12.0x$529K$26.3M49.77x118.5%
Bear Case11.0x10.0x$646K$9.6M14.87x71.6%
Bear (11x exit)11.0x11.0x$646K$10.8M16.68x75.6%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumHeavy Medicare dependenceMedicare comprises 87.6% of days; rate updates may lag inflation. Mitigant: CDI/CMI lever directly increases Medicare reimbursement

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 277 hospitals with 15-60 beds
  • Same-state prioritization (n=278)
  • Comp margins: P25=-30.8% / P50=-4.0% / P75=10.0%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.